Syncell Inc. announced the deployment of its commercial Microscoop® Mint technology at two of Europe’s foremost research ...

Rothschild views Agilent as a leading pure play in life science instruments with diverse end markets (only 34% of revenue from Pharma) and an impressive 64% recurring revenue.

GIA is a trusted authority known for its rigorous, objective analysis of both natural and cultured pearls. Learn about how ...

Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...

Headlines: Xevo CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules.1 Enables ...

Charité and Stanford scientists built a genome-to-proteome map in yeast, linking thousands of DNA mutations to changes in ...

Every organism's genome contains mutations that often have unknown biological effects. In partnership with Stanford ...

Overview of Mass Spectrometry MarketThe global Mass Spectrometry Market is valued at USD 6.51 Billion in 2024 and is projected to reach a value of USD 21.78 Billion by 2035 at a CAGR (Compound Annual ...

To explore the latest breakthroughs in proteomics, GEN spoke with five companies at the forefront of proteomic innovation.

Scientists at Max Planck Institute of Biochemistry and VIB are deploying MicroscoopMint technology to gain the most precise and unbiased view of subcellular protein activity Syncell Inc., a leader ...

SFC Europe 2025—the 19th International Conference on Packed Column Supercritical Fluid Chromatography and Related ...